Telisotuzumab vedotin Antibody

SKU: orb2279091

Description

Telisotuzumab vedotin (ABBV-399) is a c-Met-targeting antibody-drug conjugate (ADC) developed for research applications. It demonstrates antitumor activity in preclinical models of non-small cell lung cancer (NSCLC), including studies involving c-Met overexpressing squamous cell carcinoma, supporting its investigation for recurrent disease.

Research Area

Signal Transduction

Key Properties

• Antibody Type: Inhibitor Antibody
• Clonality: Recombinant
• Target: c-Met/HGFR,Antibody-Drug Conjugates (ADCs)
• Molecular Weight: 151.37 kDa
• Purity: >95.0% (May vary between batches)
• Conjugation: Unconjugated

Storage & Handling

• Storage: Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
• Concentration: 7.15 mg/mL
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

ADCs, ABBV 399, ABBV399, ABBV-399, ABT399, ABT 399, AntibodyDrugConjugates, AntibodyDrugConjugates(ADCs), Antibody-Drug Conjugates, AntibodyDrug Conjugates (ADCs), Telisotuzumab vedotin

Quick Database Links

Gene Symbol

c-Met/HGFR,Antibody-Drug Conjugates (ADCs)